Natural killer group 2D‐major histocompatibility complex class I polypeptide‐related sequence A activation enhances natural killer cell‐mediated immunity against hepatocellular carcinoma: A review

Ähnliche Einträge

• Deciphering the dual nature of the Fibrosis‐4 index in predicting hepatocellular carcinoma risk among hepatitis B patients undergoing nucleos(t)ide analog therapy
  von: Jun Arai, et al.
  Veröffentlicht: (2024)
• Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma
  von: Seung Kak Shin, et al.
  Veröffentlicht: (2024)
• Antitumor effects and immune‐mediated adverse events of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma
  von: Takanori Ito, et al.
  Veröffentlicht: (2024)
• Etiological changes of liver cirrhosis and hepatocellular carcinoma‐complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021
  von: Hirayuki Enomoto, et al.
  Veröffentlicht: (2024)
• Quantitative evaluation of tumor signal heterogeneity on gadoxetic acid‐enhanced magnetic resonance imaging as a predictor of postoperative survival and antitumor immunity in hepatocellular carcinoma
  von: Shunsuke Doi, et al.
  Veröffentlicht: (2025)